Sierra Acai Company
Sierra Acai Company
Open 7 Days a Week
MonaVie Independent Distributor
Distributor Training
Shop Online
Enroll Now
Buy Wholesale and maintain an Active status for 2 months and we will refund your $39 Distributor Fee
Friends
Buy Wholesale and maintain an Active status for 2 months and we will refund your $39 Distributor Fee
14-September-2008 18:02:49 - degrading enzyme Insulin-degrading enzyme PDB rendering based on 2g47. Available structures: 2g47, 2g48, 2g49, 2g54, 2g56 Identifiers Symbols IDE; FLJ35968; INSULYSIN External IDs OMIM: 146680 MGI: 96412 HomoloGene: 3645 Gene ontology Molecular function: insulysin activity signal transducer activity zinc ion binding metal ion binding Cellular component: extracellular space soluble fraction peroxisome Biological process: proteolysis signal transduction cell-cell signaling sex differentiation RNA expression pattern More reference expression data Orthologs Human Mouse Entrez 3416 15925 Ensembl ENSG00000119912 ENSMUSG00000056999 Uniprot P14735 Q8CGB9 Refseq NM_004969 mRNA NP_004960 protein XM_974712 mRNA XP_979806 protein Location Chr 10: 94.2 - 94.32 Mb Chr 19: 37.34 - 37.4 Mb Pubmed search 1 2 Insulin-degrading enzyme, also known as IDE, is a human gene.1 Insulin Degrading Enzyme IDE is a large zinc-binding protease of the M16A metalloprotease subfamily known to cleave multiple short polypeptides that vary considerably in sequence. Known alternatively as insulysin or insulin protease, IDE was first identified by its ability to degrade the B chain of the hormone insulin. This activity was observed over fifty years ago,2 though the enzyme specifically responsible for B chain cleavage was identified more recently.3 This discovery revealed considerable amino acid sequence homology between IDE and the previously characterized bacterial protease pitrilysin, suggesting a common proteolytic mechanism. IDE, which migrates at 110 kDa during gel electrophoresis under denaturing conditions, has since been shown to have additional substrates, including the signaling peptides glucagon, TGF alpha, and β-endorphin.4 Contents 1 IDE and Alzheimer's Disease 2 IDE Structure and Function 3 References 4 External links IDE and Alzheimer's Disease Considerable interest in IDE has been stimulated due to the discovery that IDE can degrade amyloid beta Aβ, a peptide implicated in the pathogenesis of Alzheimer's disease.5 The underlying cause or causes of the disease are unclear, though the primary neuropathology observed is the formation of amyloid plaques and neurofibrillary tangles. One hypothesized mechanism of disease, called the amyloid hypothesis, suggests that the causative agent is the hydrophobic peptide Aβ, which forms quaternary structures that, by an unclear mechanism, cause neuronal death. Aβ is a byproduct generated as the result of proteolytic processing of the amyloid precursor protein APP by proteases referred to as the β and γ secretases. The physiological role of this processing is unclear, though it may play a role in nervous system development.6 Numerous in vitro and in vivo studies have shown correlations between IDE, Aβ degradation, and Alzheimer's disease. Mice engineered to lack both alleles of the IDE gene exhibit a 50% decrease in Aβ degradation, resulting in cerebral accumulation of Aβ.7 Studies of genetically inherited forms of Alzheimer's show reduction in both IDE expression8 and catalytic activity9 among affected individuals. Despite the evident role of IDE in disease, relatively little is known about its physiological functions. These may be diverse, as IDE has been localized to several locations, including the cytosol, peroxisomes, endosomes, proteasome complexes,10 and the surface of cerebrovascular endothelial cells.11 IDE Structure and Function Structural studies of IDE by Shen et al.12 have provided insight into the functional mechanisms of the protease. Reminiscent of the previously determined structure of the bacterial protease pitrilysin, the IDE crystal structure reveals defined N and C terminal units that form a proteolytic chamber containing the zinc-binding active site. In addition, it appears that IDE can exist in two conformations: an open conformation, in which substrates can access the active site, and a closed state, in which the active site is contained within the chamber formed by the two concave domains. Targeted mutations that prevent the closed conformation result in a 40-fold increase in catalytic activity. Based upon this observation, it has been proposed that a possible therapeutic approach to Alzheimer's might involve shifting the conformational preference of IDE to the open state, and thus increasing Aβ degradation, preventing aggregation, and, ideally, preventing the neuronal loss that leads to disease symptoms. References ^ Entrez Gene: IDE insulin-degrading enzyme. ^ Mirsky IA, Broh-Kahn RH 1949. The inactivation of insulin by tissue extracts. I. The distribution and properties of insulin inactivating extracts insulinase. Arch Biochem. 20: 1-9. ^ Affholter JA, Fried VA, Roth RA 1988. Human insulin-degrading enzyme shares structural and functional homologies with E. coli protease III. Science 242 4884: 1415-8. doi:10.1126/science.3059494. PMID 3059494. ^ Wang DS, Dickson DW, Malter JS 2006. beta-Amyloid Degradation and Alzheimer's Disease. J. Biomed. Biotechnol. 2006 3: 58406. doi:10.1155/JBB/2006/58406. PMID 17047308. ^ Kurochkin IV, Goto S 1994. Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 345 1: 33-7. doi:10.1016/0014-57939400387-4. PMID 8194595. ^ Kerr ML, Small DH 2005. Cytoplasmic domain of the beta-amyloid protein precursor of Alzheimer's disease: function, regulation of proteolysis, and implications for drug development. J. Neurosci. Res. 80 2: 151-9. doi:10.1002/jnr.20408. PMID 15672415. ^ Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S 2003. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc. Natl. Acad. Sci. U.S.A. 100 7: 4162-7. doi:10.1073/pnas.0230450100. PMID 12634421. ^ Cook DG, Leverenz JB, McMillan PJ, Kulstad JJ, Ericksen S, Roth RA, Schellenberg GD, Jin LW, Kovacina KS, Craft S 2003. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele. Am. J. Pathol. 162 1: 313-9. PMID 12507914. ^ Kim M, Hersh LB, Leissring MA, Ingelsson M, Matsui T, Farris W, Lu A, Hyman BT, Selkoe DJ, Bertram L, Tanzi RE 2007. Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families. J. Biol. Chem. 282 11: 7825-32. doi:10.1074/jbc.M609168200. PMID 17244626. ^ Duckworth WC, Bennett RG, Hamel FG 1998. Insulin degradation: progress and potential. Endocr. Rev. 19 5: 608-24. doi:10.1210/er.19.5.608. PMID 9793760. ^ Lynch JA, George AM, Eisenhauer PB, Conn K, Gao W, Carreras I, Wells JM, McKee A, Ullman MD, Fine RE 2006. Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovascular endothelial cell cultures. J. Neurosci. Res. 83 7: 1262-70. doi:10.1002/jnr.20809. PMID 16511862. ^ Shen Y, Joachimiak A, Rosner MR, Tang WJ 2006. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature 443 7113: 870-4. doi:10.1038/nature05143. PMID 17051221. External links MeSH Insulin-Degrading+Enzyme v d e Proteases: metalloendopeptidases EC 3.4.24 ADAM proteins Alpha secretases ADAM9 · ADAM10 · ADAM17 · ADAM19 · ADAM2 · ADAM7 · ADAM8 · ADAM11 · ADAM12 · ADAM15 · ADAM18 · ADAM22 · ADAM23 · ADAM28 · ADAM33 · ADAMTS1 · ADAMTS2 · ADAMTS3 · ADAMTS4 · ADAMTS5 · ADAMTS8 · ADAMTS9 · ADAMTS10 · ADAMTS12 · ADAMTS13 Matrix metalloproteinase Collagenase · Gelatinase Other Neprilysin · Procollagen peptidase · Thermolysin · Pregnancy-associated plasma protein A · Bone morphogenetic protein 1 · Insulysin · Lysostaphin · Insulin degrading enzyme Retrieved from http://en..org/wiki/Insulin_degrading_enzyme Categories: Genes on chromosome 10 | Human proteins | Enzymes Views Article Discussion this page History Personal tools Log in / create account Navigation Main page Contents Featured content Current events Random article Search Go Search Interaction Community portal Recent changes Contact Donate to Help Toolbox What links here Related changes Upload file Special pages Printable version Permanent link Cite this page This page was last modified on 8 July 2008, at 04:49
39 Reasons to Drink Acai Juice Every Day
What is MonaVie - Watch the 8-minute video
Discovering MonaVie Video
The Power of You Video
Effects of MonaVie Active on Antioxidant Capacity in Humans
Log into your Wholesale MonaVie Account
So many of us do not eat a balanced diet, get enough sleep, have too much stress, or are impacted with toxins and pollutants. Drinking 2 ounces of MonaVie twice a day will help your body detoxify as well as build your immune system. Its the smartest thing you can do for yourself, so start today. Buying MonaVie through our company guarantees you support 7 days a week and, if you would like to share MonaVie with your family and friends we will guide you from start to finish.
1. Click on Enroll Now (30 - 55% off retail price)
2. Pay $39 for your Wholesale ID number.
3. NO minimum order required.
4. MonaVie is delivered to your door in 3 to 5 days.